Dutasteride Capsule, Liquid Filled
Product Images NDC 50090-4010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 50090-4010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
FDA Label Image

Fig4 (Fig4)

Fig4 (Fig4)
FDA Label Image

Fig5 (Fig5)

Fig5 (Fig5)
FDA Label Image

Fig6 (Fig6)

Fig6 (Fig6)
FDA Label Image

Fig7 (Fig7)

Fig7 (Fig7)
FDA Label Image

Label Image (Lbl500904010)

Label Image (Lbl500904010)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Tab1 (Tab1)

Tab1 (Tab1)
Adverse Reaction Time of Onset Adverse Reaction | Months 0-6 | Months 7-12 | Months 13-18 | Months 19-24 Dutasteride: - Impotence: 47% (0-6 months), 14% (7-12 months), 1.0% (13-18 months), 0.8% (19-24 months) - Decreased libido: 30% (0-6 months), 0.7% (7-12 months), 0.3% (13-18 months), 0.3% (19-24 months) - Ejaculation disorders: 14% (0-6 months), 0.5% (7-12 months), 0.5% (13-18 months), 0.1% (19-24 months) - Breast disorders: 5% (0-6 months), 0.8% (7-12 months), 1.1% (13-18 months), 0.6% (19-24 months) Placebo: - Impotence: 17% (0-6 months), 15% (7-12 months), 0.5% (13-18 months), 0.9% (19-24 months) - Decreased libido: 14% (0-6 months), 0.6% (7-12 months), 0.2% (13-18 months), 0.1% (19-24 months) - Ejaculation disorders: 5% (0-6 months), 0.3% (7-12 months), 0.1% (13-18 months), 0.0% (19-24 months) - Breast disorders: 2% (0-6 months), 0.3% (7-12 months), 0.3% (13-18 months), 0.1% (19-24 months) This data shows the percentage of adverse reactions reported for the drug Dutasteride compared to a placebo over different time periods. Some of the adverse reactions include impotence, decreased libido, ejaculation disorders, and breast disorders. The percentages vary depending on the duration of drug use.*
FDA Label Image

Tab2 (Tab2)

Tab2 (Tab2)
This text appears to be a table or chart showing the adverse reactions and their time of onset for three different medications: Combination, Dutasteride, and Tamsulosin. The adverse reactions listed include ejaculation disorders, impotence, decreased libido, breast disorders, and dizziness. The percentages indicate the prevalence of each adverse reaction at different time intervals (e.g., Year 1, Year 2, Months 0-6, Months 7-12). Unfortunately, the text is not very clear and some of the values are unreadable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.